- HEALTH INFORMATION
- GET SUPPORT
- NEWS & VIEWS
- GET INVOLVED
- CARE PROVIDERS
In conjunction with the International Society for the Study of Hypertension in Pregnancy (ISSHP) Brazilian Chapter's First Annual International Preeclampsia Summit in Sao Paulo on July 16-17, the Preeclampsia Foundation announced that Brazil would be its first international partnership site. This announcement is part of the global drive to improve maternal health care and provide healthcare providers with life-saving educational resources. As part of the Brazilian Preeclampsia Summit, the Preeclampsia Foundation provided a short introductory video, as well as patient education materials that featured our new Portuguese prescription pad.
The Brazilian chapter of the Preeclampsia Foundation was solidified with a handshake on March 3, 2009 in Bellagio, Italy.
Conference organizer Dr. Nelson Sass and Preeclampsia Foundation Executive Director Eleni Tsigas met in March 2009 at a meeting in Bellagio, Italy and discussed the development of a plan to expand international preeclampsia awareness. The plan came to fruition as the Foundation became a presenting partner in the first meeting of ISSHP-Brazil, sending in a prerecorded video "welcome" message and encouraging clinicians to use symptom pads that the Foundation had specially produced in Portuguese, as well as providing basic informational brochures.
The Preeclampsia Foundation Community Forum has long been a key component of our international patient support outreach, with thousands of members from all over the world swapping advice and stories of their own personal experiences. In order to better serve such a diverse population and to help others receive the critical patient education and support that the forum has to offer, the Preeclampsia Foundation has recently partnered with international volunteer Thaís Facca to provide a Portuguese language section.
In the future, the Preeclampsia Foundation plans to identify more in-country opportunities to partner with Brazilian preeclampsia researchers and clinicians and continue to foster mutually beneficial partnerships.